347 related articles for article (PubMed ID: 29229440)
1. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.
Molina JM; Charreau I; Chidiac C; Pialoux G; Cua E; Delaugerre C; Capitant C; Rojas-Castro D; Fonsart J; Bercot B; Bébéar C; Cotte L; Robineau O; Raffi F; Charbonneau P; Aslan A; Chas J; Niedbalski L; Spire B; Sagaon-Teyssier L; Carette D; Mestre SL; Doré V; Meyer L;
Lancet Infect Dis; 2018 Mar; 18(3):308-317. PubMed ID: 29229440
[TBL] [Abstract][Full Text] [Related]
2. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design.
Molina JM; Bercot B; Assoumou L; Rubenstein E; Algarte-Genin M; Pialoux G; Katlama C; Surgers L; Bébéar C; Dupin N; Ouattara M; Slama L; Pavie J; Duvivier C; Loze B; Goldwirt L; Gibowski S; Ollivier M; Ghosn J; Costagliola D;
Lancet Infect Dis; 2024 May; ():. PubMed ID: 38797183
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
[TBL] [Abstract][Full Text] [Related]
4. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM;
Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
[TBL] [Abstract][Full Text] [Related]
6. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
Luetkemeyer AF; Donnell D; Dombrowski JC; Cohen S; Grabow C; Brown CE; Malinski C; Perkins R; Nasser M; Lopez C; Vittinghoff E; Buchbinder SP; Scott H; Charlebois ED; Havlir DV; Soge OO; Celum C;
N Engl J Med; 2023 Apr; 388(14):1296-1306. PubMed ID: 37018493
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women.
Stewart J; Oware K; Donnell D; Violette LR; Odoyo J; Soge OO; Scoville CW; Omollo V; Mogaka FO; Sesay FA; McClelland RS; Spinelli M; Gandhi M; Bukusi EA; Baeten JM;
N Engl J Med; 2023 Dec; 389(25):2331-2340. PubMed ID: 38118022
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial.
Van Dijck C; Tsoumanis A; Rotsaert A; Vuylsteke B; Van den Bossche D; Paeleman E; De Baetselier I; Brosius I; Laumen J; Buyze J; Wouters K; Lynen L; Van Esbroeck M; Herssens N; Abdellati S; Declercq S; Reyniers T; Van Herrewege Y; Florence E; Kenyon C
Lancet Infect Dis; 2021 May; 21(5):657-667. PubMed ID: 33676596
[TBL] [Abstract][Full Text] [Related]
9. Australian consensus statement on doxycycline post-exposure prophylaxis (doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men.
Cornelisse VJ; Riley B; Medland NA
Med J Aust; 2024 Apr; 220(7):381-386. PubMed ID: 38479437
[TBL] [Abstract][Full Text] [Related]
10. Doxycycline as Postsexual Exposure Prophylaxis: Use, Acceptability, and Associated Sexual Health Behaviors Among a Multi-Site Sample of Clinical Trial Participants.
Fredericksen RJ; Perkins R; Brown CE; Cannon C; Lopez C; Cohee A; Dombrowski JC; Cohen S; Malinski C; Powell M; Luetkemeyer AF; Celum C; Christopoulos K
AIDS Patient Care STDS; 2024 Apr; 38(4):155-167. PubMed ID: 38656217
[TBL] [Abstract][Full Text] [Related]
11. HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.
Buchbinder SP; Glidden DV; Liu AY; McMahan V; Guanira JV; Mayer KH; Goicochea P; Grant RM
Lancet Infect Dis; 2014 Jun; 14(6):468-75. PubMed ID: 24613084
[TBL] [Abstract][Full Text] [Related]
12. Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial.
Stewart J; Bukusi E; Sesay FA; Oware K; Donnell D; Soge OO; Celum C; Odoyo J; Kwena ZA; Scoville CW; Violette LR; Morrison S; Simoni J; McClelland RS; Barnabas R; Gandhi M; Baeten JM
Trials; 2022 Jun; 23(1):495. PubMed ID: 35710444
[TBL] [Abstract][Full Text] [Related]
13. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
[TBL] [Abstract][Full Text] [Related]
14. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
[TBL] [Abstract][Full Text] [Related]
15. High Prevalence and High Rate of Antibiotic Resistance of Mycoplasma genitalium Infections in Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Pre-exposure Prophylaxis Trial.
Berçot B; Charreau I; Rousseau C; Delaugerre C; Chidiac C; Pialoux G; Capitant C; Bourgeois-Nicolaos N; Raffi F; Pereyre S; Le Roy C; Senneville E; Meyer L; Bébéar C; Molina JM;
Clin Infect Dis; 2021 Oct; 73(7):e2127-e2133. PubMed ID: 33305785
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Ogbuagu O; Ruane PJ; Podzamczer D; Salazar LC; Henry K; Asmuth DM; Wohl D; Gilson R; Shao Y; Ebrahimi R; Cox S; Kintu A; Carter C; Das M; Baeten JM; Brainard DM; Whitlock G; Brunetta JM; Kronborg G; Spinner CD;
Lancet HIV; 2021 Jul; 8(7):e397-e407. PubMed ID: 34197772
[TBL] [Abstract][Full Text] [Related]
17. Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Mayer KH; Molina JM; Thompson MA; Anderson PL; Mounzer KC; De Wet JJ; DeJesus E; Jessen H; Grant RM; Ruane PJ; Wong P; Ebrahimi R; Zhong L; Mathias A; Callebaut C; Collins SE; Das M; McCallister S; Brainard DM; Brinson C; Clarke A; Coll P; Post FA; Hare CB
Lancet; 2020 Jul; 396(10246):239-254. PubMed ID: 32711800
[TBL] [Abstract][Full Text] [Related]
18. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
Molina JM; Capitant C; Spire B; Pialoux G; Cotte L; Charreau I; Tremblay C; Le Gall JM; Cua E; Pasquet A; Raffi F; Pintado C; Chidiac C; Chas J; Charbonneau P; Delaugerre C; Suzan-Monti M; Loze B; Fonsart J; Peytavin G; Cheret A; Timsit J; Girard G; Lorente N; Préau M; Rooney JF; Wainberg MA; Thompson D; Rozenbaum W; Doré V; Marchand L; Simon MC; Etien N; Aboulker JP; Meyer L; Delfraissy JF;
N Engl J Med; 2015 Dec; 373(23):2237-46. PubMed ID: 26624850
[TBL] [Abstract][Full Text] [Related]
19. CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.
Bachmann LH; Barbee LA; Chan P; Reno H; Workowski KA; Hoover K; Mermin J; Mena L
MMWR Recomm Rep; 2024 Jun; 73(2):1-8. PubMed ID: 38833414
[TBL] [Abstract][Full Text] [Related]
20. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study.
Laurent C; Dembélé Keita B; Yaya I; Le Guicher G; Sagaon-Teyssier L; Agboyibor MK; Coulibaly A; Traoré I; Malan JB; De Baetselier I; Eubanks A; Riegel L; Rojas Castro D; Fayé-Ketté H; Koné A; Diandé S; Dagnra CA; Serrano L; Diallo F; Mensah E; Dah TTE; Anoma C; Vuylsteke B; Spire B;
Lancet HIV; 2021 Jul; 8(7):e420-e428. PubMed ID: 34048794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
